Ultrasmall T1-T2 Magnetic Resonance Multimodal Imaging Nanoprobes for the Detection of β-amyloid Aggregates in Alzheimer's Disease Mice
Ultrasmall T1-T2 Magnetic Resonance Multimodal Imaging Nanoprobes for the Detection of β-amyloid Aggregates in Alzheimer's Disease Mice
复制标题
超小型 T-1-T-2 磁共振多模态成像纳米探针用于检测阿尔茨海默病小鼠中的 β-淀粉样蛋白聚集体
DOI:
10.1021/acsami.0c01597
复制
发表时间:
2020-06-17
影响因子:
9.5
通讯作者:
Li, Li
中科院分区:
文献类型:
--
作者:
Cai, Jing;Yi, Peiwei;Li, Li
Alzheimer's disease (AD) is an irreversible brain disorder and imposes a severe burden upon patients and the public health system. Most research efforts have focused on the search for effective therapeutic drugs, but it is time to pursue efficient early diagnosis based on the reasonable assumption that AD may be easier to prevent than reverse. Recent studies have shown that there are several probes for detecting amyloid-beta (A beta) plaques, one of the neuropathological hallmarks found in AD brain. However, it is still a great challenge for nonradioactive, sensitive detection and location of A beta plaques by brain imaging with high spatial resolution. Herein, phenothiazine derivative (PZD)-conjugated sub-5 nm ultrasmall ferrite nanoprobes (UFNPs@PEG/PZD) are designed and prepared for efficient T-1 -T-2 magnetic resonance multimodal imaging of A beta plaques. UFNPs@PEG/PZD not only possess high binding affinity to A beta plaques but also exhibit excellent properties of r(1) and r(2) relaxivities. This study thus provides a promising ultrasmall nanoplatform as an A beta-targeting multimodal imaging probe for the application of early diagnosis of AD.